Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis due to high post-resection recurrence, yet current prognostic tools inadequately capture systemic tumor-host interactions. This study developed and validated a novel CT-based body composition radiomics model for predicting recurrence-free survival (RFS) in 191 PDAC patients undergoing curative resection. Using a temporal validation design (training cohort: 2019–2022, n = 142; validation cohort: 2016–2018, n = 49), we extracted 1,688 radiomics features from adipose and muscle tissues at the L3 vertebral level. Following a standardized feature selection protocol (variance filtering, correlation reduction, and Cox regression), we constructed fat- and muscle-specific radiomics scores, combining them into a unified risk stratification system. The combined model effectively identified high-risk patients with significantly reduced RFS (HR = 6.455, p < 0.001), achieving consistent performance across cohorts (C-index: 0.71 training, 0.69 validation). This approach quantifies metabolic alterations in body composition, providing a clinically actionable tool to guide personalized therapy decisions—including intensified neoadjuvant regimens for high-risk patients or standard surveillance for low-risk individuals.
Objective: To stage liver fibrosis by using delayed dual-energy CT (DECT) and determine the optimal delay time for acquisition of delayed CT scans. Materials and methods: This prospective study included patients with chronic liver disease, who were scheduled to undergo multiphase abdominal DECT (including 3-min and 5-min delayed periods) and liver biopsies from January 2021 to December 2021. The iodine densities of the parenchyma and aorta were measured and extracellular volume (ECV) was calculated. Kendall rank correlation was employed to assess the relationship between the ECV and the fibrosis stage. Comparison of ECVs was made for different stages of liver fibrosis. In addition, the diagnostic performances of ECV for staging liver fibrosis were evaluated by using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) was calculated. Results: A total of 90 participants were evaluated, and distributed as follows: 10 in S1, 29 in S2, 25 in S3, and 26 in S4. Both ECV of 3-min delayed (ECV3 min) and 5-min delayed (ECV5 min) showed a positive correlation with the stage of liver fibrosis (ECV3 min: τ = 0.478, P < .01, moderate correlation; ECV5 min: τ = 0.352, P < .01, weak correlation). In terms of diagnostic performances, ECV3 min showed significantly higher diagnostic accuracy than ECV5 min for significant liver fibrosis (S2–4) (AUC: 0.87 vs 0.79, P = .037), but no significant differences were observed for progressive fibrosis (S3–4) (AUC: 0.76 vs 0.71, P = .206) or cirrhosis (S4) (AUC: 0.75 vs 0.74, P = .774). Conclusions: DECT ECV may have some potential in noninvasively liver fibrosis staging, ECV3 min is not definitely inferior to ECV5 min. Advances in knowledge: A 3-min delay for the delayed-phase ECV assessment can guide clinical treatment decisions for patients and enhance the efficiency of scanning work, holding significant clinical value.
1 November 2024 in Journal of Hepatocellular Carcinoma
Purpose: This study aims to explore the value of radiomics combined with clinical parameters in predicting recurrence-free survival (RFS) after the resection of hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, a total of 322 patients with HCC who underwent contrast-enhanced computed tomography (CT) and radical surgical resection were enrolled and randomly divided into a training group (n = 223) and a validation group (n = 97). In the training group, Univariate and multivariate Cox regression analyses were employed to obtain clinical variables related to RFS for constructing the clinical model. The least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were employed to construct the radiomics model, and the clinical-radiomics model was further constructed. Model prediction performance was subsequently assessed by the area under the time-dependent receiver operating characteristic curve (AUC) and calibration curve. Additionally, Kaplan-Meier analysis was used to evaluate the model’s value in predicting RFS. Correlations between radiomics features and pathological parameters were analyzed. Results: The clinical-radiomics model predicted RFS at 1, 2, and 3 years more accurately than the clinical or radiomics model alone (training group, AUC = 0.834, 0.765 and 0.831, respectively; validation group, AUC = 0.715, 0.710 and 0.793, respectively). The predicted high-risk subgroup based on the clinical-radiomics nomogram had shorter RFS than predicted low-risk subgroup in data sets, enabling risk stratification of various clinical subgroups. Correlation analysis revealed that the rad-score was positively related to microvascular invasion (MVI) and Edmondson-Steiner grade. Conclusion: The clinical-radiomics model effectively predicts RFS in HCC patients and identifies high-risk individuals for recurrence.
12 April 2023 in Diagnostic and Interventional Imaging